cemiplimab (libtayo) Report issue

Biologics mAb Approved FDA
AACT Drugs@FDA
Back

Drug Pricing Summary

VA Big4

$6909.6800

VA FSS

$9054.2700

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
cemiplimab 50 mg / 1 mL (1 mL INJECTION) $6909.6800 VA Big4
  • LIBTAYO (1)
    		•  Regeneron Pharmaceuticals, Inc.
    cemiplimab 50 mg / 1 mL (1 mL INJECTION) $9054.2700 VA FSS
  • LIBTAYO (1)
    		•  Regeneron Pharmaceuticals, Inc.

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue